EBITDA was negative $17.5 million, versus $13.0 million in the Q3 2023, essentially due to an asset impairment charge. Adjusted EBITDA amounted to $7.9 million, compared to $11.7 million for the same period last year.
EBITDA was negative $17.5 million, versus $13.0 million in the Q3 2023, essentially due to an asset impairment charge. Adjusted EBITDA amounted to $7.9 million, compared to $11.7 million for the same period last year.